# reload+after+2024-01-21 09:46:37.177073
address1§Darwinweg 24
city§Leiden
zip§2333 CR
country§Netherlands
phone§31 71 524 7400
fax§31 71 524 7445
website§https://www.pharming.com
industry§Biotechnology
sector§Healthcare
longBusinessSummary§Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company's commercialized product is RUCONEST, a plasma-free rhC1INH protein replacement therapy for the treatment acute hereditary angioedema (HAE) attacks. It also engages in the development of leniolisib for the treatment of activated phosphoinositide 3-kinase delta syndrome; OTL-105, an investigational ex-vivo autologous hematopoietic stem cell gene therapy for the treatment of HAE; and alpha-glucosidase therapy for the treatment of Pompe and fabry diseases. The company has a development collaboration and license agreement with Novartis; and a strategic collaboration agreement with Orchard Therapeutics plc for research, development, manufacturing, and commercialization of OTL-105. Pharming Group N.V. is headquartered in Leiden, the Netherlands.
fullTimeEmployees§332
companyOfficers§[{'maxAge': 1, 'name': 'Dr. Sijmen  de Vries M.B.A., M.D.', 'age': 64, 'title': 'President, CEO & Executive Director', 'yearBorn': 1959, 'fiscalYear': 2022, 'totalPay': 1176000, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Jeroen  Wakkerman', 'age': 54, 'title': 'Chief Financial Officer', 'yearBorn': 1969, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Mireille  Sanders M.Sc.', 'age': 55, 'title': 'Chief Operations Officer', 'yearBorn': 1968, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Susanne  Embleton', 'title': 'Investor Relations Manager', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Ruud  Van Outersterp', 'age': 59, 'title': 'Chief Ethics & Compliance Officer', 'yearBorn': 1964, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Daniela Dos Anjos Hanovana', 'title': 'Chief People Officer', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Anurag  Relan M.D., MPH', 'age': 51, 'title': 'Chief Medical Officer', 'yearBorn': 1972, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Stephen  Toor', 'age': 52, 'title': 'Chief Commercial Officer & GM Americas', 'yearBorn': 1971, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Alexander  Breidenbach M.B.A.', 'title': 'Chief Business Officer', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Bruno M. L. Giannetti', 'age': 71, 'title': 'Consultant', 'yearBorn': 1952, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
auditRisk§7
boardRisk§1
compensationRisk§7
shareHolderRightsRisk§4
overallRisk§4
governanceEpochDate§1704067200
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§2
payoutRatio§0.0
beta§0.776
priceToSalesTrailing12Months§3.6839166
currency§USD
dateShortInterest§1702598400
exchange§NGM
quoteType§EQUITY
shortName§Pharming Group N.V.
longName§Pharming Group N.V.
firstTradeDateEpochUtc§1608733800
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§5db69536-7ef9-35ef-8d96-33da6cebf0ca
gmtOffSetMilliseconds§-18000000
recommendationKey§none
quickRatio§3.498
earningsGrowth§-0.615
grossMargins§0.88859004
ebitdaMargins§-0.07898
trailingPegRatio§None
